
pmid: 41540926
pmc: PMC12811710
During the early 2025/26 influenza season, influenza A(H3N2) subclade K rapidly predominated in Beijing, China. Using a test-negative design, we estimated influenza vaccine effectiveness (VE) among influenza-like illness outpatients tested between September and December 2025. Among 9,579 participants, sequencing of 316 randomly selected A(H3N2)-positive samples showed 84.8% were subclade K, and antigenic analysis of 65 viruses indicated antigenic divergence. Despite this, adjusted VE against laboratory-confirmed influenza was 41.3% (95% CI: 29.2 to 51.3), indicating moderate protection during this subclade K-dominated season.
Male, Adult, China, Adolescent, Influenza A Virus, H3N2 Subtype, Vaccination, Vaccine Efficacy, Infant, Middle Aged, Young Adult, Influenza Vaccines, Beijing, Child, Preschool, Influenza, Human, Humans, Female, Seasons, Child, Antigens, Viral
Male, Adult, China, Adolescent, Influenza A Virus, H3N2 Subtype, Vaccination, Vaccine Efficacy, Infant, Middle Aged, Young Adult, Influenza Vaccines, Beijing, Child, Preschool, Influenza, Human, Humans, Female, Seasons, Child, Antigens, Viral
| citations The total number of citations received by all articles of the researcher of interest. | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
